98 related articles for article (PubMed ID: 11122567)
1. Fast, aggressive treatment for myocardial infarction urged.
Mitka M
JAMA; 2000 Dec; 284(23):2985-6. PubMed ID: 11122567
[No Abstract] [Full Text] [Related]
2. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes.
Campbell P
N Engl J Med; 2001 Nov; 345(21):1573-4; author reply 1574-5. PubMed ID: 11794228
[No Abstract] [Full Text] [Related]
3. Routine vs selective invasive strategies in acute coronary syndromes.
Bavry AA; Kumbhani DJ
JAMA; 2005 Dec; 294(22):2844-5; author reply 2845-6. PubMed ID: 16352787
[No Abstract] [Full Text] [Related]
4. [Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Fries R; Böhm M
Med Klin (Munich); 2003 Jun; 98(6):326-34. PubMed ID: 12811417
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
7. Management of acute coronary syndromes.
Garcia-Pavia P; Aguiar-Souto P; Silva-Melchor L
N Engl J Med; 2005 Dec; 353(25):2714-8; author reply 2714-8; discussion 2714-8. PubMed ID: 16379084
[No Abstract] [Full Text] [Related]
8. Tirofiban and intracoronary stenting: evaluation of a new pharmacologic regimen.
Amidon TM; Amidon JB; Benson JM; Coffler D
J Invasive Cardiol; 1999 Dec; 11(12):718-21. PubMed ID: 10745471
[TBL] [Abstract][Full Text] [Related]
9. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
10. Managing unstable angina in high-risk patients.
Chew DP; Moliterno DJ
J Invasive Cardiol; 2002 Feb; 14 Suppl A():31A-48A. PubMed ID: 11847404
[No Abstract] [Full Text] [Related]
11. Management of acute coronary syndromes.
Newby DE; Fox KA
N Engl J Med; 2005 Dec; 353(25):2714-8; author reply 2714-8; discussion 2714-8. PubMed ID: 16379085
[No Abstract] [Full Text] [Related]
12. Diabetes mellitus and unstable coronary artery disease: improved clinical outcome of coronary artery stenting in an era of glycoprotein IIb/IIIa inhibitors and lipid-lowering therapy.
Voudris VA; Skoularigis JS; Dimitriou YK; Grapsa GN; Malakos JS; Pavlides GS; Manginas AN; Cokkinos DV
Coron Artery Dis; 2004 Sep; 15(6):353-9. PubMed ID: 15346094
[TBL] [Abstract][Full Text] [Related]
13. Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
De Servi S; Mariani M; Vandoni P; Dellavalle A; Politi A; Poletti F; Bonizzoni E; Leoncinie M;
J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):159-65. PubMed ID: 16645379
[TBL] [Abstract][Full Text] [Related]
14. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
Catheter Cardiovasc Interv; 2000 Dec; 51(4):505-21. PubMed ID: 11108692
[No Abstract] [Full Text] [Related]
15. Timing of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Naina HV; Harris S; Singla A
JAMA; 2007 Jul; 298(1):37; author reply 37-8. PubMed ID: 17609485
[No Abstract] [Full Text] [Related]
16. Acute coronary syndrome: new advances and nursing strategies.
Palatnik AM
Dimens Crit Care Nurs; 2000; 19(5):22-6. PubMed ID: 11998062
[TBL] [Abstract][Full Text] [Related]
17. Using eptifibatide in patients undergoing coronary angioplasty with acute myocardial infarction.
Wong CB
Catheter Cardiovasc Interv; 2003 Nov; 60(3):423-4; author reply 424. PubMed ID: 14571498
[No Abstract] [Full Text] [Related]
18. Unstable angina treatment: 2006 update.
Wehrmacher WH
Compr Ther; 2006; 32(3):144-6. PubMed ID: 17435265
[TBL] [Abstract][Full Text] [Related]
19. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
[No Abstract] [Full Text] [Related]
20. [Glycoprotein IIb/IIIa antagonists].
Hennemann A
Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
